C07D 265/18
With hetero atoms directly attached in position 2
Official title: with hetero atoms directly attached in position 2
C07D265/18 (With hetero atoms directly attached in position 2) appears on 132 US grants and 142 published applications in this corpus.
Search patents in C07D- Granted patents
- 132
- Published applications
- 142
- Assignees
- 85
- Inventors
- 424
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 1 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 3 |
| 2003 | 4 | 5 |
| 2004 | 2 | 5 |
| 2005 | 2 | 7 |
| 2006 | 1 | 11 |
| 2007 | 4 | 8 |
| 2008 | 7 | 2 |
| 2009 | 3 | 7 |
| 2010 | 5 | 15 |
| 2011 | 4 | 10 |
| 2012 | 10 | 15 |
| 2013 | 10 | 9 |
| 2014 | 6 | 3 |
| 2015 | 7 | 5 |
| 2016 | 4 | 9 |
| 2017 | 7 | 3 |
| 2018 | 3 | 4 |
| 2019 | 2 | 5 |
| 2020 | 3 | 2 |
| 2021 | 3 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 5 |
| 2024 | 0 | 2 |
| 2025 | 4 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors17 Mar 2026US 12,581,252 B2D. E. Shaw Research, LLC
- Compound having neuroprotective effect, preparation method therefor and use thereof18 Nov 2025US 12,473,276 B2Shanghai Zhimeng Biopharma, Inc.
- Deuterated analogs of etifoxine, their derivatives and uses thereof7 Oct 2025US 12,433,896 B2Gaba Therapeutics Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Apr 2025US 12,268,783 B2Theaprin Pharmaceuticals Inc.
- Substituted isoindolines as PI3K-alpha inhibitors4 Feb 2025US 12,219,327 B2D. E. Shaw Research, LLC
- Raf-mek protein complex modulators and methods of use thereof1 Oct 2026US 2026/0297105 A1Gandeeva Therapeutics, Inc.
- Pi3k-alpha inhibitors and methods of use thereof16 Jul 2026US 2026/0205746 A1D. E. Shaw Research, LLC
- Sarm1 modulators, preparations, and uses thereof16 Oct 2025US 2025/0320184 A1Sironax Ltd.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jul 2025US 2025/0228778 A1Theaprin Pharmaceuticals Inc.
- Benzoxazinone derivatives as selective cytotoxic agents12 Dec 2024US 2024/0409531 A1Merck Sharp & Dohme Corp.
Most cited
By later US patents
- 6-amino-1,4-dihydro-benzo[d][1,3] oxazin-2-ones and analogs useful as progesterone receptor modulators251US 7,247,625 B2Wyeth · 2007
- Benzoxazinones as inhibitors of HIV reverse transcriptase83US 5,519,021 AMerck & Co., Inc. · 1996
- Cyclothiocarbamate derivatives as progesterone receptor modulators63US 6,436,929 B1Ligand Pharmaceuticals Incorporated · 2002
- Bicyclic androgen and progesterone receptor modulator compounds and methods61US 6,566,372 B1Ligand Pharmaceuticals Incorporated · 2003
- 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same60US 5,874,430 ADuPont Pharmaceuticals Company · 1999